Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Precipio Inc (PRPO)

Precipio Inc (PRPO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Insider Sale: Director at $PRPO (PRPO) Sells 12,000 Shares

RICHARD A SANDBERG, a director at $PRPO ($PRPO), sold 12,000 shares of the company on 12-13-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 72.6% of their...

PRPO : 5.82 (-6.71%)
Two Smaller Companies Worthy of Your "Attention"

Elite Pharmaceuticals Inc. (ELTP) fits nicely into the nexus of the increasing diagnoses of ADHD and the patent expiration of the branded drug Vyanse in 2023 for its treatment. Elite Pharmaceuticals Inc....

ELTP : 0.4925 (-10.13%)
PRPO : 5.82 (-6.71%)
Precipio Announces Q3-2024 Shareholder Update Call

PRPO : 5.82 (-6.71%)
Precipio Expands Bloodhoundâ„¢ MPN Panel by Adding CALR Mutation Subtyping

PRPO : 5.82 (-6.71%)
Zacks Initiates Coverage of Precipio With Outperform Recommendation

Zacks Investment Research has recently initiated coverage of Precipio, Inc. PRPO, assigning an "Outperform" recommendation to the company's shares. This bullish stance reflects the company's path to profitability...

PRPO : 5.82 (-6.71%)
Toni-Ann Mills Joins Precipio’s Products Division to Lead Channel Partner Training, Learning & Development

Precipio prepares to launch a nationwide HemeScreen sales effort of 250+ sales reps from AmerisourceBergen, ThermoFisher, and other distributors ...

PRPO : 5.82 (-6.71%)
Precipio Announces Second Quarter Shareholder Update Call

Conference Call to be held on Monday, August 15th, 2022 at 5:00 PM EST...

PRPO : 5.82 (-6.71%)
Precipio to distribute HemeScreen® through Fisher Healthcare channel

Agreement Enhances Precipio’s Product Reach to US Laboratories...

PRPO : 5.82 (-6.71%)
Precipio requests that all Stockholders that have not yet voted, proceed to cast their vote

Meeting Adjourned, new meeting set for July 5th at 10am EDT...

PRPO : 5.82 (-6.71%)
Keith Meadors Joins Precipio to Lead its Products Division

Seasoned, experienced industry executive with a track record of managing 9-figure revenue sales organizations...

PRPO : 5.82 (-6.71%)

Barchart Exclusives

How to Profitably Exploit a Temporary Sentiment Reversal in Planet Labs (PL)
While PL stock has been one of the surprise winners this year, a corrective lull isn’t out of the question. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar